RVMD

Revolution Medicines, Inc.

29.94 USD
-0.02 (-0.07%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Revolution Medicines, Inc. stock is up 5.98% since 30 days ago. The next earnings date is May 6, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 4 February’s closed higher than January. In the last 5 Unusual Options Trades, there were 5 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
16 Jan 14:45 19 Jan, 2024 12.50 CALL 435 3
31 Jan 20:06 20 Sep, 2024 26.00 CALL 46 0
31 Jan 20:10 20 Sep, 2024 28.00 CALL 56 0
16 Feb 19:09 15 Mar, 2024 35.00 CALL 436 62
27 Feb 16:52 21 Jun, 2024 33.00 CALL 100 6

About Revolution Medicines, Inc.

Revolution Medicines, Inc. focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trials for solid tumors, such as gynecologic and colorectal cancer tumors.